subsidiary

Sweden-based Immunovia is preparing to launch its first diagnostic — a liquid biopsy test for pancreatic cancer — in 2018.

The subsidiary is being formed in support of Biocartis' recent US distribution deal with Thermo Fisher Scientific.

Jason Terrell will lead the subsidiary, which will be based in Austin, Texas.